Koers Integrative Health Technologies, Inc. Other OTC
Aandelen
IHTI
US45822A2078
Biotechnologie & Medisch Onderzoek
Omzet 2008 | 0,43 0,4 | Omzet 2009 | 0,45 0,42 | Marktkapitalisatie | 1,22 mln. 1,14 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2008 | - 0 | Nettowinst (verlies) 2009 | - 0 | EV/omzet 2008 | 14.379.727 x |
Nettoschuld 2008 | 99,02K 92,3K | Nettoschuld 2009 | 94,3K 87,89K | EV/omzet 2009 | 2.939.517 x |
K/w-verhouding 2008 |
231
x | K/w-verhouding 2009 |
31,6
x | Werknemers | - |
Dividendrendement 2008 * |
-
| Dividendrendement 2009 |
-
| Vrij verhandelbaar | 48,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Samuel C. Keith
CIO | Chief Investment Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,77% | 42,86 mld. | |
+45,32% | 41,36 mld. | |
+12,24% | 42,74 mld. | |
-8,83% | 27,68 mld. | |
+7,44% | 25,15 mld. | |
-23,01% | 18,63 mld. | |
+30,56% | 12,37 mld. | |
-1,82% | 11,92 mld. | |
+8,35% | 11,21 mld. |